HEPION PHARMACEUTICALS, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2024-07-24: Federal exemption Rule 506(b); Types of securities offered Equity; Debt; Date of first sale 2024-07-19; Total offering amount $2,900,000.
- 2023-10-03: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2023-09-28; Total offering amount $5,000,004.
- 2022-11-15: Federal exemption Rule 506(b); Types of securities offered Equity; Sale and issuance of Series F preferred stock and Series G preferred stock and the underlying shares of Common Stock issuable upon the conversion thereof; Date of first sale 2022-11-04; Total offering amount $20,000,000.
- 2019-03-27: Federal exemption Rule 506(b); Types of securities offered Equity; Debt; Date of first sale 2019-03-13; Total offering amount $1,250,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2024-07-24 | Rule 506(b) | Equity; Debt | 2024-07-19 | $2,900,000 | $2,900,000 | $0 | 7 |
|---|
| 2023-10-03 | Rule 506(b) | Equity; OptionToAcquire | 2023-09-28 | $5,000,004 | $5,000,004 | $0 | 1 |
|---|
| 2022-11-15 | Rule 506(b) | Equity; Sale and issuance of Series F preferred stock and Series G preferred stock and the underlying shares of Common Stock issuable upon the conversion thereof | 2022-11-04 | $20,000,000 | $20,000,000 | $0 | 8 |
|---|
| 2019-03-27 | Rule 506(b) | Equity; Debt | 2019-03-13 | $1,250,000 | $1,250,000 | $0 | 1 |
|---|
| 2014-02-14 | Rule 506(b) | Equity; OptionToAcquire | 2014-02-04 | $3,225,000 | $3,225,000 | $0 | 19 |
|---|